Literature DB >> 9614324

Transmission-blocking effects of sera from malaria-exposed individuals on Plasmodium falciparum isolates from gametocyte carriers.

C J Drakeley1, L Mulder, T Tchuinkam, S Gupta, R Sauerwein, G A Targett.   

Abstract

Sera from donors exposed to malaria were tested for their ability to block the transmission of isolates from Cameroonian Plasmodium falciparum gametocyte carriers. Sera were selected from amongst Cameroonian and Gambian donors who had positive antibody reactivity against the surface of activated gametes and against epitopes of Pfs 48/45 (a potential transmission-blocking vaccine candidate antigen). Aliquots of washed blood from gametocyte carriers were resuspended in test and control sera and fed to An. gambiae mosquitoes via a membrane feeder. Comparisons of the prevalence and intensity of infections is dissected mosquitoes showed variations in the ability of sera to block the transmission of the different isolates. Sera were identified that had little or no blocking effect on the transmission of isolates unless the isolate was poorly infectious. Some sera completely blocked the transmission of some isolates whilst having little or no effect on others. The observed variation in transmission-modulating activity may have implications for the development of a transmission-blocking vaccine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614324     DOI: 10.1017/s0031182098002601

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  8 in total

Review 1.  Approaches to malaria vaccine development using the retrospectroscope.

Authors:  Vanessa Sardá; David C Kaslow; Kim C Williamson
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

Review 2.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  [Humoral response to Plasmodium falciparum antigenic peptides (MSP1, MSP2, and SR-11.1) in subjects living in endemic areas].

Authors:  Yacouba Sourabié; Yétéma Dieudonné Yonli; Francis Fumoux; Yves Traoré
Journal:  Pan Afr Med J       Date:  2022-03-28

4.  Sex and death: the effects of innate immune factors on the sexual reproduction of malaria parasites.

Authors:  Ricardo S Ramiro; João Alpedrinha; Lucy Carter; Andy Gardner; Sarah E Reece
Journal:  PLoS Pathog       Date:  2011-03-03       Impact factor: 6.823

5.  Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.

Authors:  Will J R Stone; Joseph J Campo; André Lin Ouédraogo; Lisette Meerstein-Kessel; Isabelle Morlais; Dari Da; Anna Cohuet; Sandrine Nsango; Colin J Sutherland; Marga van de Vegte-Bolmer; Rianne Siebelink-Stoter; Geert-Jan van Gemert; Wouter Graumans; Kjerstin Lanke; Adam D Shandling; Jozelyn V Pablo; Andy A Teng; Sophie Jones; Roos M de Jong; Amanda Fabra-García; John Bradley; Will Roeffen; Edwin Lasonder; Giuliana Gremo; Evelin Schwarzer; Chris J Janse; Susheel K Singh; Michael Theisen; Phil Felgner; Matthias Marti; Chris Drakeley; Robert Sauerwein; Teun Bousema; Matthijs M Jore
Journal:  Nat Commun       Date:  2018-02-08       Impact factor: 14.919

Review 6.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

Review 7.  Recent advances in recombinant protein-based malaria vaccines.

Authors:  Simon J Draper; Evelina Angov; Toshihiro Horii; Louis H Miller; Prakash Srinivasan; Michael Theisen; Sumi Biswas
Journal:  Vaccine       Date:  2015-10-11       Impact factor: 3.641

8.  Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings.

Authors:  André Lin Ouédraogo; Philip A Eckhoff; Adrian J F Luty; Will Roeffen; Robert W Sauerwein; Teun Bousema; Edward A Wenger
Journal:  PLoS Pathog       Date:  2018-05-09       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.